Validation of celiac disease diagnoses recorded in the danish national patient register using duodenal biopsies, celiac disease-specific antibodies, and human leukocyte-antigen genotypes

Stine Dydensborg Sander, Ketil Størdal, Tine Plato Hansen, Anne Marie Nybo Andersen, Joseph A. Murray, Søren Thue Lillevang, Steffen Husby

Research output: Contribution to journalArticle

10 Scopus citations

Abstract

Purpose: The purpose of this study was to validate the celiac disease diagnoses recorded in the Danish National Patient Register. To validate the diagnoses, we used information on duodenal biopsies from a national register of pathology reports (the Patobank) and information on celiac disease-specific antibodies and human leukocyte antigen (HLA) genotypes obtained from patient medical records. Patients and methods: We included all the children who were born from 1995 to 2012 and who were registered as having celiac disease in the Danish National Patient Register. We reviewed all the pathology reports on duodenal biopsies in the Patobank and the information in the medical records on celiac disease-specific antibodies (ie, anti-tissue transglutaminase 2 IgA and IgG, endomysial antibodies IgA, and anti-deamidated gliadin peptide IgG) and HLA genotypes. Results: We identified 2,247 children who were registered in the Danish National Patient Register with celiac disease. Duodenal biopsies for 1,555 of the children (69%) were registered in the Patobank; 1,127 (50%) had a biopsy that was compatible with celiac disease (ie, Marsh 2–3). We accessed the medical records of 95% of the children who were registered in the Danish National Patient Register with celiac disease. We found that 1,510 (67%) had one or more positive antibody-test results; 1,120 (50%) had anti-tissue transglutaminase 2, IgA at tenfold or greater the upper limit of the normal range and/or positive endomysial antibody results. The positive predictive value depended on the criteria used for validation and the types and numbers of registrations that were included in the analysis and ranged from 62% (95% confidence interval: 60%–64%) to 86% (95% confidence interval: 84%–87%). Conclusion: Our findings indicate that the Danish National Patient Register is a valuable source to identify patients who have been diagnosed with celiac disease. However, validation of the diagnoses is warranted before data on the patients are used for research purposes.

Original languageEnglish (US)
Pages (from-to)789-799
Number of pages11
JournalClinical Epidemiology
Volume8
DOIs
StatePublished - Dec 15 2016

Keywords

  • Administrative health register
  • Histology
  • Medical record
  • National patient register
  • Pathology register
  • Serology

ASJC Scopus subject areas

  • Epidemiology

Fingerprint Dive into the research topics of 'Validation of celiac disease diagnoses recorded in the danish national patient register using duodenal biopsies, celiac disease-specific antibodies, and human leukocyte-antigen genotypes'. Together they form a unique fingerprint.

  • Cite this